Endogenous lectins as mediators of tumor cell adhesion

Abstract

Endogenous carbohydrate‐binding proteins have been found in various normal tissues and cells. Although lectins with different sugar‐binding specificities have been described, the most prevalent ones are those that bind β‐galactosides. The ability of some normal and malignant cells to bind exogenous carbohydrate‐containing ligands suggested that lectinlike activity is associated with the cell surface and that carbohydrate‐binding proteins might mediate intercellular recognition and adhesion. We found that extracts of various cultured murine and human tumor cells exhibit a galactoside‐inhibitable hemagglutinating activity. This activity was associated with two proteins of molecular weights of 34,000 and 14,500 daltons, which were purified by affinity chromatography by using immobilized asialofetuin. That these lectins are present on the cell surface was indicated by the binding of monoclonal antilectin antibodies to the surface of various tumor cells and by the immunoprecipitation of ¹²⁵I‐labeled lectins from solubilized cell‐surface iodinated cells by polyclonal anti‐lectin antibodies. That these cell surface lectins are functional was demonstrated by the ability of the galactose‐terminating asialofetuin to enhance cell aggregation and of asialofetuin glycopeptides to block this homotypic aggregation as well as to suppress cell attachment to substratum, and by the inhibition of both asialofetuin‐induced cell aggregation and cell attachment to substratum by the binding of monoclonal antilectin antibodies to the cell surface. These findings implicate cell surface lectins as mediators of cell‐cell and cell‐substratum adhesion. Some of these cellular interactions might be important determinants of tumor cell growth and metastasis.